HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manami Hara Selected Research

galactonic acid

6/2015Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manami Hara Research Topics

Disease

6Insulin Resistance
10/2019 - 02/2002
4Glucose Intolerance
10/2021 - 02/2002
4Hyperglycemia
10/2021 - 02/2004
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2015 - 08/2004
3Type 2 Diabetes Mellitus (MODY)
06/2004 - 04/2002
2Inflammation (Inflammations)
01/2016 - 06/2015
2Diabetes Mellitus
01/2009 - 08/2004
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
06/2004 - 02/2002
1Hypoglycemia (Reactive Hypoglycemia)
01/2020
1Pancreatic Diseases (Pancreatic Disease)
01/2018
1Metabolic Diseases (Metabolic Disease)
01/2018
1Permanent Neonatal Diabetes Mellitus
01/2017
1Hypertriglyceridemia
06/2015
1Mason-Type Diabetes
04/2009
1Type 3 Maturity-Onset Diabetes of the Young
04/2009
1Teratoma (Teratoid Tumor)
01/2009
1Solitary Kidney
12/2006
1Diabetic Neuropathies (Diabetic Neuropathy)
08/2005
1Wounds and Injuries (Trauma)
08/2004
1Hyperinsulinism (Hyperinsulinemia)
04/2004
1Obesity
04/2004
1Thyroid Diseases (Thyroid Disease)
04/2004
1Noninsulin-dependent diabetes mellitus with deafness
04/2004

Drug/Important Bio-Agent (IBA)

6Glucose (Dextrose)FDA LinkGeneric
10/2021 - 02/2004
6Insulin (Novolin)FDA Link
10/2021 - 02/2004
3C-PeptideIBA
08/2015 - 04/2004
3ProinsulinIBA
08/2005 - 02/2004
2DNA (Deoxyribonucleic Acid)IBA
04/2004 - 04/2002
1Dynamins (Dynamin)IBA
10/2021
1Glucagon (Glukagon)FDA Link
01/2020
1Endocrine DisruptorsIBA
01/2018
1ArsenicIBA
01/2018
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2018
1Drinking WaterIBA
01/2018
1Hormones (Hormone)IBA
01/2016
1AdiponectinIBA
01/2016
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2016
1EicosanoidsIBA
06/2015
1galactonic acidIBA
06/2015
1Cysteine (L-Cysteine)FDA Link
06/2015
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2015
1LactonesIBA
06/2015
1LipidsIBA
06/2015
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
06/2015
1Methionine (L-Methionine)FDA Link
06/2015
1Phosphatidylcholines (Phosphatidylcholine)IBA
06/2015
1threonic acid (threonate)IBA
06/2015
1Arachidonic Acid (Vitamin F)IBA
06/2015
1Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA
04/2009
1Green Fluorescent ProteinsIBA
01/2009
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
03/2008
1Streptozocin (Streptozotocin)FDA Link
03/2008
1Capsules (Microcapsules)IBA
12/2006
1Glycogen Synthase (Synthase I)IBA
06/2004
1GlycogenIBA
06/2004
1ElementsIBA
06/2004
1Protein Phosphatase 1IBA
06/2004
1Cysteine Proteases (Cysteine Protease)IBA
04/2002
1PPAR gammaIBA
02/2002
1LigandsIBA
02/2002
1ThiazolidinedionesIBA
02/2002

Therapy/Procedure

2Injections
01/2017 - 02/2004
1Glycemic Control
01/2018
1Intraperitoneal Injections
03/2008
1Cell Transplantation
12/2006
1Islets of Langerhans Transplantation
08/2004
1Transplantation
08/2004